| Theme |
Life Style and Digestive Diseases |
| Title |
Microflora Targeted Therapies for Inflammatory Bowel Disease: Pro- and Prebiotics |
| Author |
Keiichi Mitsuyama |
Second Department of Medicine, Kurume University School of Medicine |
| Author |
Satoshi Matsumoto |
Yakult Central Institute for Microbiological Research |
| [ Summary ] |
Although the causes of the inflammatory bowel disease remain incompletely understood, increasing evidence implicates intestinal microflora in the pathogenesis of these disorders. Modulation of the intestinal flora therefore may offer a plausible therapeutic approach. While recent data support a potential therapeutic role for probiotics, prebiotics and synbiotics, such treatments need to be further assessed by large scale studies. A better understanding of the intestinal microflora and the mechanisms of their action may help us to develop more effective treatments for inflammatory bowel disease. |